Trials / No Longer Available
No Longer AvailableNCT01747382
Renal Denervation for Treatment of Resistant Hypertension in Patients With Chronic Kidney Disease
Catheter-based Renal Sympathetic Nerve Ablation for Treatment-resistant Hypertension in Patients With Chronic Kidney Disease
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Singapore General Hospital · Academic / Other
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Recent clinical studies have demonstrated that catheter-based renal sympathetic nerve ablation is safe and effective in treating patients with resistant hypertension. However, there is limited data on its safety and efficacy in patients with Chronic Kidney Disease. The investigators hypothesize that catheter-based renal sympathetic nerve ablation is safe and effective in the treatment of resistant hypertension in patients with Chronic Kidney Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Renal denervation |
Timeline
- Start date
- 2012-04-01
- Primary completion
- 2015-09-01
- Completion
- 2017-09-01
- First posted
- 2012-12-11
- Last updated
- 2017-05-02
Locations
2 sites across 1 country: Singapore
Source: ClinicalTrials.gov record NCT01747382. Inclusion in this directory is not an endorsement.